Profile | GDS2987 / GI_41209794-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | ||
GSM215244 | HMVEC_vehicle_rep2 | ||
GSM215253 | HMVEC_vehicle_rep3 | 8 | 27 |
GSM215254 | HMVEC_atorvastatin_rep1 | ||
GSM215282 | HMVEC_atorvastatin_rep3 | 0.8 | 2 |
GSM215344 | HMVEC_atorvastatin_rep2 | 18.1 | 41 |
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | 27.9 | 47 |
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 4.1 | 9 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | ||
GSM215294 | HMVEC_SLx2119_rep1 | 41.4 | 69 |
GSM215295 | HMVEC_SLx2119_rep2 | ||
GSM215296 | HMVEC_SLx2119_rep3 | 41.2 | 56 |
GSM215297 | PASMC_vehicle_rep1 | ||
GSM215298 | PASMC_vehicle_rep2 | 15.8 | 24 |
GSM215310 | PASMC_vehicle_rep3 | ||
GSM215311 | PASMC_atorvastatin_rep1 | 33.6 | 50 |
GSM215312 | PASMC_atorvastatin_rep2 | 21.7 | 33 |
GSM215313 | PASMC_atorvastatin_rep3 | ||
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | 2.7 | 5 |
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 17.2 | 32 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | ||
GSM215327 | PASMC_SLx2119_rep1 | 33.7 | 50 |
GSM215328 | PASMC_SLx2119_rep2 | 34.1 | 52 |
GSM215329 | PASMC_SLx2119_rep3 | 44.6 | 61 |
GSM215330 | Fibroblasts_vehicle_rep1 | 27.6 | 52 |
GSM215331 | Fibroblasts_vehicle_rep2 | 42.2 | 66 |
GSM215332 | Fibroblasts_vehicle_rep3 | 48.6 | 69 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 7.2 | 20 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 21.5 | 50 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 24.7 | 51 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 16.2 | 47 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 14.7 | 43 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | ||
GSM215339 | Fibroblasts_SLx2119_rep1 | 37.9 | 65 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 48.2 | 68 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 44.8 | 66 |